Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.

Paclitaxel has demonstrated broad clinical activity in a variety of malignancies both alone and in combination with other chemotherapeutic agents. The in vitro cytotoxicity of a 2 h exposure to paclitaxel, hydroperoxy-ifosfamide and etoposide alone, in combination and in sequence, was evaluated agai...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Klaassen, U., Harstrick, A., Schleucher, N., Vanhoefer, U., Schröder, J., Wilke, H., Seeber, S.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1996
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074580/
https://ncbi.nlm.nih.gov/pubmed/8688325
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares